Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Christopher Yea > Profile

Christopher Yea

Affiliations

  • Chief Development Officer at Kalvista Pharmaceuticals Inc. (KALV), 2025-02-26
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
Kalvista Pharmaceuticals Inc.
 KALV $10.02 1,918 93,952 2025-02-24 Filing
Kalvista Pharmaceuticals Inc.
 KALV $9.82 2,601 92,745 2025-02-18 Filing
Kalvista Pharmaceuticals Inc.
 KALV $9.87 1,963 91,142 2024-11-26 Filing
Kalvista Pharmaceuticals Inc.
 KALV $9.26 7,192 89,980 2024-11-18 Filing
Kalvista Pharmaceuticals Inc.
 KALV $12.40 1,916 85,676 2024-08-23 Filing